Li, H., Wang, Z., Zhang, J., Wang, Y., Yu, C., Zhang, J., . . . Lv, C. (2018). Feifukang ameliorates pulmonary fibrosis by inhibiting JAK-STAT signaling pathway. BMC Complement Altern Med.
Chicago ZitierstilLi, Hongbo, Zhenkai Wang, Jie Zhang, Youlei Wang, Chen Yu, Jinjin Zhang, Xiaodong Song, und Changjun Lv. "Feifukang Ameliorates Pulmonary Fibrosis By Inhibiting JAK-STAT Signaling Pathway." BMC Complement Altern Med 2018.
MLA ZitierstilLi, Hongbo, et al. "Feifukang Ameliorates Pulmonary Fibrosis By Inhibiting JAK-STAT Signaling Pathway." BMC Complement Altern Med 2018.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.